Literature DB >> 10672415

Pathways involved in trifluoperazine-, dibucaine- and praziquantel-induced hemolysis.

S V Malheiros1, N C Meirelles, E de Paula.   

Abstract

This work elucidates differences in the hemolytic pathway developed by the antipsychotic trifluoperazine (TFP), the local anesthetic dibucaine (DBC) and the antihelminthic praziquantel (PZQ). Their partition coefficients (P) were measured at pH 7.4 between n-octanol, microsomes, liposomes, erythrocyte ghosts and n-octanol/water. The effective drug:lipid molar ratios for the onset of membrane solubilization (ReSAT) and complete hemolysis (ReSOL) were calculated from the experimental P values and compared with a classical surface-active compound treatment Lichtenberg, D. Biochim. Biophys. Acta 821 (1985) 470-478[. The contribution of charged/uncharged forms of TFP and DBC for the hemolytic activity was also analyzed. In all cases the hemolytic phenomena could be related to the monomeric drug insertion into the membrane. Only for TFP at isosmotic condition lysis occurs at concentrations beyond the CMC of the drug, indicating that micellization facilitates TFP hemolytic effect, while DBC and PZQ reach a real membrane saturation at their monomeric form.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10672415     DOI: 10.1016/s0301-4622(99)00125-8

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  8 in total

Review 1.  Biophysical approaches in the study of biomembrane solubilization: quantitative assessment and the role of lateral inhomogeneity.

Authors:  Karin A Riske; Cleyton C Domingues; Bruna R Casadei; Bruno Mattei; Amanda C Caritá; Rafael B Lira; Paulo S C Preté; Eneida de Paula
Journal:  Biophys Rev       Date:  2017-08-23

2.  Relationship between the affinity of PEO-PPO-PEO block copolymers for biological membranes and their cellular effects.

Authors:  Martin Redhead; Giuseppe Mantovani; Selina Nawaz; Paola Carbone; Dariusz C Gorecki; Cameron Alexander; Cynthia Bosquillon
Journal:  Pharm Res       Date:  2012-03-03       Impact factor: 4.200

3.  Environmental stresses and clinical drugs paralyze a cell.

Authors:  Yukifumi Uesono
Journal:  Commun Integr Biol       Date:  2009-05

4.  Resistance of human erythrocyte membranes to Triton X-100 and C12E8.

Authors:  Cleyton Crepaldi Domingues; Annarita Ciana; Armando Buttafava; Cesare Balduini; Eneida de Paula; Giampaolo Minetti
Journal:  J Membr Biol       Date:  2008-12-09       Impact factor: 1.843

5.  Synthesis and biological evaluation of rigid polycyclic derivatives of the Diels-Alder adduct tricyclo[6.2.1.02,7]undeca-4,9-dien-3,6-dione.

Authors:  Felicia Megumi Ito; Jacqueline Marques Petroni; Dênis Pires de Lima; Adilson Beatriz; Maria Rita Marques; Manoel Odorico de Moraes; Letícia Veras Costa-Lotufo; Raquel Carvalho Montenegro; Hemerson Iury Ferreira Magalhães; Cláudia do O Pessoa
Journal:  Molecules       Date:  2007-02-27       Impact factor: 4.411

6.  Development, characterization, and in vitro biological performance of fluconazole-loaded microemulsions for the topical treatment of cutaneous leishmaniasis.

Authors:  Marcela Brito Oliveira; Giovana Calixto; Márcia Graminha; Hugo Cerecetto; Mercedes González; Marlus Chorilli
Journal:  Biomed Res Int       Date:  2015-01-12       Impact factor: 3.411

7.  Structural characterization and in vitro antioxidant activity of kojic dipalmitate loaded w/o/w multiple emulsions intended for skin disorders.

Authors:  Maíra Lima Gonçalez; Diana Gleide Marcussi; Giovana Maria Fioramonti Calixto; Marcos Antonio Corrêa; Marlus Chorilli
Journal:  Biomed Res Int       Date:  2015-02-15       Impact factor: 3.411

8.  Topical application of retinyl palmitate-loaded nanotechnology-based drug delivery systems for the treatment of skin aging.

Authors:  Marcela B Oliveira; Alice Haddad do Prado; Jéssica Bernegossi; Claudia S Sato; Iguatemy Lourenço Brunetti; Maria Virgínia Scarpa; Gislaine Ricci Leonardi; Stig E Friberg; Marlus Chorilli
Journal:  Biomed Res Int       Date:  2014-03-19       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.